Effect of the Single or Combined Administration of Cocaine and Testosterone on Cardiovascular Function and Baroreflex Activity in Unanesthetized Rats


Autoria(s): Engi, Sheila A.; Cruz, Fabio C.; Leao, Rodrigo M.; Correa, Fernando M.; Planeta, Cleopatra S.; Crestani, Carlos C.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

Abuse of cocaine and androgenic-anabolic steroids has become a serious public health problem. Despite reports of an increase in the incidence of simultaneous illicit use of these substances, potential toxic interactions between cocaine and androgenic-anabolic steroids in the cardiovascular system are unknown. In the present study, we investigated the effect of single or combined administration of testosterone and cocaine for 1 or 10 consecutive days on basal cardiovascular parameters, baroreflex activity, and hemodynamic responses to vasoactive agents in unanesthetized rats. Ten-day combined administration of testosterone and cocaine increased baseline arterial pressure. Changes in arterial pressure were associated with altered baroreflex activity and impairment of both hypotensive response to intravenous sodium nitroprusside and pressor effect of intravenous phenylephrine. Chronic single administration of either testosterone or cocaine did not affect baseline arterial pressure. However, testosterone-treated animals presented rest bradycardia, cardiac hypertrophy, alterations in baroreflex activity, and enhanced response to sodium nitroprusside. Repeated administration of cocaine affected baroreflex activity and impaired vascular responsiveness to both sodium nitroprusside and phenylephrine. One-day single or combined administration of the drugs did not affect any parameter investigated. In conclusion, the present results suggest a potential interaction between toxic effects of cocaine and testosterone on the cardiovascular activity. Changes in baseline arterial pressure after combined administration of these 2 drugs may result from alterations in baroreflex activity and impairment of vascular responsiveness to vasoactive agents.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/16192-8]

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [474177/2010-6]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas

Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas

Fundacao para Desenvolvimento da UNESP

Fundacao para Desenvolvimento da UNESP

Identificador

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, PHILADELPHIA, v. 59, n. 3, supl. 1, Part 1, pp. 231-240, MAR, 2012

0160-2446

http://www.producao.usp.br/handle/BDPI/41911

10.1097/FJC.0b013e31823cc58b

http://dx.doi.org/10.1097/FJC.0b013e31823cc58b

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

PHILADELPHIA

Relação

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Direitos

closedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #ABUSE #ANABOLIC STEROIDS #COCAINE #CARDIOVASCULAR #HYPERTENSION #HYPERTROPHY #VASCULAR REACTIVITY #SPONTANEOUSLY HYPERTENSIVE RATS #ANABOLIC-ANDROGENIC STEROIDS #VASCULAR REACTIVITY #CONSCIOUS RATS #HEART-RATE #NITRIC-OXIDE #NANDROLONE #RESPONSES #TOXICITY #ADOLESCENTS #CARDIAC & CARDIOVASCULAR SYSTEMS #PHARMACOLOGY & PHARMACY
Tipo

article

original article

publishedVersion